Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 17 Dec 2025

Madhya Pradesh forms panel to probe HIV infection among 6 children

Business Standard

The Madhya Pradesh government has formed a six-member committee to investigate how six children suffering from blood disorder thalassemia, including four treated at a hospital in Satna, contracted HIV infection, officials said. Tarun Rathi, Commissioner of the Public Health and Medical Education Department, issued an order on Tuesday announcing the formation of the investigation team and directed it to submit a report within seven days. The six children in the age group of 12 to 15 were found to be HIV positive after suspected contaminated blood transfusions at the district hospitals in Satna, Jabalpur and elsewhere. The parents of one of them were also found to be infected, officials said on Tuesday. Satna Collector Satish Kumar S told reporters that these infection cases came to light between January and May this year, and all the victims are currently undergoing treatment. "Children suffering from thalassemia were receiving regular blood transfusions. Six of them were found to b

Pharmaceuticals & Biotech.

SECTOR | 16 Dec 2025

Odisha unveils Pharma, MedTech Policy 2025, eyes 25,000 crore investment

Business Standard

The Odisha government on Tuesday unveiled Pharmaceutical and Medical Devices Policy-2025, aiming to attract investment of Rs 25,000 crore and create 1 lakh jobs by 2030. Chief Minister Mohan Charan Majhi launched the new policy here at the Odisha Pharma Summit-2025 in the presence of Industries Minister Sampad Chandra Swain and senior government officers. Speaking on the occasion, Industries Department's Additional Chief Secretary Hemant Sharma said India imports about 85 per cent of medical devices from other countries, and there is a huge opportunity for this sector. As a lot of units of pharmaceutical and medical devices are expected to come up in the next five years, Odisha must make an attempt to become a part of this endeavour, Sharma said. Under the policy, the state offers a 50 per cent subsidy on concessional land cost for units employing more than 200 Odisha-domiciled skilled staff. The government also offered a 30 per cent capital subsidy on eligible plant and machinery

Pharmaceuticals & Biotech.

SECTOR | 15 Dec 2025

Biocon launches drugs for diabetes and obesity treatment in Netherlands

Business Standard

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for liraglutide from the Medicines and Healthcare Products Regulatory Agency

Pharmaceuticals & Biotech.

SECTOR | 08 Dec 2025

HIV-free for seven years after cancer treatment, and doctors are amazed

Business Standard

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 mutation once seen as essential, shifting cure research

Pharmaceuticals & Biotech.

SECTOR | 05 Dec 2025

From hugs to food to tattoos: Debunking 16 dangerous myths about HIV

Business Standard

From casual contact and mosquito bites to tattoos, pregnancy, PrEP, and treatment, specialists debunk the misconceptions that fuel stigma and delay diagnosis

Pharmaceuticals & Biotech.

SECTOR | 04 Dec 2025

Pharmaceutical sector set to gain from rupee fall despite API dependence

Business Standard

Exporters like Sun Pharma, Dr Reddy's may see 7-8% revenue lift, yet margins pressured by high raw material import costs

Pharmaceuticals & Biotech.

SECTOR | 03 Dec 2025

How poor diabetes management increases complications in people with HIV

Business Standard

Experts warn that poor sugar control pushes HIV-related health risks higher, leading to faster progression of heart, kidney and nerve problems

Pharmaceuticals & Biotech.

SECTOR | 02 Dec 2025

Can HIV be cured? New research shows long-term remission may be closer

Business Standard

Early trial results show that combining antibodies and T-cells helped some people living with HIV maintain viral control for months without daily ART, raising cautious hope for long-term remission

How soon HIV symptoms appear, and why most people don't notice them

Business Standard | 02 Dec 2025 5 more

Pharmaceuticals & Biotech.

SECTOR | 02 Dec 2025

Dr Reddy's, Cipla, Biocon, Sun Pharma In Focus After WHO Issues Guideline On Use Of GLP-1 Drugs For Obesity

NDTV Profit

In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.

Pharmaceuticals & Biotech.

SECTOR | 01 Dec 2025

Birth control in HIV: What women can safely use and what doctors warn about

Business Standard

HIV-positive women have several safe birth-control options, but viral load, ART interactions, treatment stability still guide what doctors recommend for reliable contraception and partner protection